The risk of musculoskeletal adverse outcomes after treatment with endocrine blocking treatments for breast cancer (MSKAI)

09/12/2020
22/02/2024
EU PAS number:
EUPAS38362
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

MSK_AI_Protocol_1.4 for EU PAS

English (905.49 KB - PDF) View document
Updated protocol

MSK_AI_Protocol_1.5 for EU PAS

First published: 22/02/2024
English (905.41 KB - PDF) View document
Study results
Study report
Other information